DENISE SHERK: Open Payments
NPI 1356681985 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,618 in 108 payments from 18 companies in 2025. Trend: 2023 $456 · 2024 $1,547 · 2025 $2,618
Food & beverage: $2,519Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $432 |
| Madrigal Pharmaceuticals | 29 | $417 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $416 |
| Janssen Biotech, Inc. | 14 | $304 |
| Celltrion USA Inc. | 8 | $198 |
| Regeneron Healthcare Solutions, Inc. | 3 | $178 |
| Ardelyx, Inc. | 5 | $147 |
| Lilly USA, LLC | 2 | $97 |
| Aimmune Therapeutics, Inc. | 1 | $91 |
| Gilead Sciences, Inc. | 3 | $78 |
Products named: REZDIFFRA, XIFAXAN, TREMFYA, LINZESS, VEGZELMA, IBSRELA, CREON, VOWST.
Industry payments across CA — which companies pay providers there.
